Harrow, Inc. Proceeds from Stock Options Exercised
Harrow, Inc. (HROW) reported Proceeds from Stock Options Exercised of $836.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-10
- Harrow, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $811.00K, a 695.10% increase year-over-year.
- Harrow, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $25.00K, a 8.70% increase year-over-year.
- Harrow, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $180.00K, a 71.43% increase year-over-year.
- Harrow, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $162.00K, a 66.53% decline year-over-year.
- Harrow, Inc. proceeds from stock options exercised for fiscal 2025 was $467.00K, a 57.93% decline from fiscal 2024.
- Harrow, Inc. proceeds from stock options exercised for fiscal 2024 was $1.11M, a 192.88% increase from fiscal 2023.
- Harrow, Inc. proceeds from stock options exercised for fiscal 2023 was $379.00K, a 40.97% decline from fiscal 2022.
- Harrow, Inc. proceeds from stock options exercised for fiscal 2022 was $642.00K, a 887.69% increase from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 0 month | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $836.00K 10-Q · filed 2026-08-10 | $1.02M derived: sum of 3 quarters · filed 2026-08-10 | $1.18M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-11 | $205.00K derived: sum of 2 quarters · filed 2026-05-11 | $367.00K derived: sum of 3 quarters · filed 2026-05-11 | $469.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $342.00K derived: sum of 2 quarters · filed 2026-03-02 | $444.00K derived: sum of 3 quarters · filed 2026-08-10 | $467.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $264.00K derived: sum of 2 quarters · filed 2026-08-10 | $287.00K 10-Q · filed 2025-11-10 | $392.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $125.00K 10-Q · filed 2026-08-10 | $230.00K derived: sum of 3 quarters · filed 2026-08-10 | $714.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $23.00K 10-Q · filed 2026-05-11 | $128.00K derived: sum of 2 quarters · filed 2026-05-11 | $612.00K derived: sum of 3 quarters · filed 2026-05-11 | $785.00K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $589.00K derived: sum of 2 quarters · filed 2026-03-02 | $762.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.11M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $657.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.00M 10-Q · filed 2025-11-10 | $1.03M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $521.00K 10-Q · filed 2025-08-11 | $545.00K derived: sum of 3 quarters · filed 2026-03-02 | $563.00K derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $348.00K 10-Q · filed 2025-05-08 | $372.00K derived: sum of 2 quarters · filed 2026-03-02 | $390.00K derived: sum of 3 quarters · filed 2026-03-02 | $579.00K derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $42.00K derived: sum of 2 quarters · filed 2026-03-02 | $231.00K derived: sum of 3 quarters · filed 2026-03-02 | $379.00K 10-K · filed 2026-03-02 | |
| 2023-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $207.00K derived: sum of 2 quarters · filed 2024-11-14 | $355.00K 10-Q · filed 2024-11-14 | $990.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $337.00K 10-Q · filed 2024-08-07 | $972.00K derived: sum of 3 quarters · filed 2024-08-07 | $972.00K derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | $148.00K 10-Q · filed 2024-05-13 | $783.00K derived: sum of 2 quarters · filed 2024-05-13 | $783.00K derived: sum of 3 quarters · filed 2024-05-13 | $786.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $635.00K derived: sum of 2 quarters · filed 2024-03-19 | $638.00K derived: sum of 3 quarters · filed 2024-03-19 | $642.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.00K derived: sum of 2 quarters · filed 2023-11-13 | $7.00K 10-Q · filed 2023-11-13 | $7.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.00K 10-Q · filed 2023-08-09 | $7.00K derived: sum of 3 quarters · filed 2023-08-09 | $24.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-11 | $4.00K derived: sum of 2 quarters · filed 2023-05-11 | $21.00K derived: sum of 3 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $17.00K derived: sum of 2 quarters · filed 2023-03-23 | $65.00K 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $65.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $48.00K 10-Q · filed 2022-08-09 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | $1.17M derived: sum of 3 quarters · filed 2016-03-23 | $1.25M 10-K · filed 2016-03-23 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.17M derived: sum of 2 quarters · filed 2015-11-12 | $1.25M 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $1.25M 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $77.00K 10-Q · filed 2015-05-13 | ||||
| 2013-02-13 | $1.32M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |